26 Week Efficacy And Safety Of Etranacogene Dezaparvovec (Aav5-Padua Hfix Variant; Amt-061) In Adults With Severe Or Moderate-Severe Hemophilia B Treated In The Phase 3 Hope-B Clinical Trial
Etranacogene Dezaparvovec
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: 26 Week Efficacy And Safety Of Etranacogene Dezaparvovec (Aav5-Padua Hfix Variant; Amt-061) In Adults With Severe Or Moderate-Severe Hemophilia B Treated In The Phase 3 Hope-B Clinical Trial ### Output: Etranacogene Dezaparvovec